Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Friday's Pre-Market Session

 

Gainers

  • Finch Therapeutics Group (NASDAQ:FNCH) stock increased by 55.7% to $3.27 during Friday's pre-market session. The company's market cap stands at $155.5 million.
  • Zymeworks (NYSE:ZYME) stock rose 47.78% to $7.33. The company's market cap stands at $423.2 million.
  • Summit Therapeutics (NASDAQ:SMMT) stock moved upwards by 40.36% to $2.33. The company's market cap stands at $228.6 million.
  • NuCana (NASDAQ:NCNA) stock moved upwards by 9.45% to $0.81. The company's market cap stands at $42.2 million. As per the press release, Q4 earnings came out 2 days ago.
  • 4d pharma (NASDAQ:LBPS) stock increased by 9.06% to $3.85. The company's market cap stands at $86.7 million.
  • Aquestive Therapeutics (NASDAQ:AQST) shares rose 8.63% to $1.51. The market value of their outstanding shares is at $62.5 million.

Losers

  • Genocea Biosciences (NASDAQ:GNCA) shares declined by 43.4% to $0.23 during Friday's pre-market session. The market value of their outstanding shares is at $13.5 million.
  • Accolade (NASDAQ:ACCD) shares fell 41.51% to $6.47. The market value of their outstanding shares is at $433.2 million. As per the news, the Q4 earnings report came out yesterday.
  • Statera BioPharma (NASDAQ:STAB) stock fell 15.82% to $0.32. The market value of their outstanding shares is at $16.0 million.
  • Aldeyra Therapeutics (NASDAQ:ALDX) stock fell 12.06% to $3.21. The company's market cap stands at $187.1 million.
  • Evoke Pharma (NASDAQ:EVOK) shares declined by 11.63% to $0.44. The company's market cap stands at $14.4 million.
  • Aclarion (NASDAQ:ACON) stock declined by 7.84% to $2.0. The market value of their outstanding shares is at $15.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.